ブルサテリンの類似体への動物による非リボソーム経路
Aarthi Venugopalan1, Eric W Schmidt1
1Department of Medicinal Chemistry, University of Utah, Salt Lake City, Utah 84112, United States.
Journal of the American Chemical Society
|February 11, 2025
まとめ
海洋モルシックは新しい生物合成経路で 有毒なブルサテリン・オクサジニンを産生する. この発見により 軟体動物は
科学分野:
- 海洋自然産物の化学
- 動物の生化学とゲノミクス
- 自然製品の生物合成
背景:
- ブルサテリン・オクサジニンは,モルルシクに見られるタイロシン系天然産物です.
- これらの化合物は40年間毒性に関連していましたが,その起源は不明でした.
- 以前の研究では 軟体動物における 生合成経路の理解が欠けていました
研究 の 目的:
- 軟体動物におけるブルサテリン型代謝物の生物合成起源を特定する.
- ブルサテリンの生物合成経路に関わる遺伝子を生化学的に特徴づける
- 軟体動物におけるこれらの化合物の進化的および生態学的重要性を調査する.
主な方法:
- 遺伝子クラスターを特定するために,軟体動物ゲノムとトランスクリプトームのバイオ情報分析.
- 特定された経路 (bur-ox) 内の重要な酵素の生化学的特徴.
- メタボリト合成における還元と改変のステップを明らかにするための酵素測定.
主要な成果:
- 軟体動物における新しいブルサテリン生物合成遺伝子群 (ブルオックス経路) の発見
- 生物化学的証拠によると これらの化合物は 微生物の共生体ではなく 軟体動物で作られています
- 非リボソームペプチド合成酵素 (NRPS) と,重要な合成ステップに関与するアミノカルボキシプロピルトランスフェラーゼ (ACT) 酵素の特徴.
結論:
- 軟体動物は,ブルサテリンのような化合物を合成するためのユニークな動物由来NRPS経路を持っています.
- ブルオックス経路の広範な分布は,これらの代謝産物の共通の起源と生理学的役割を示唆する.
- 食用双弁動物に存在することは,オクサジニンの毒性に関する疑問を提起し,動物の化学的多様性を強調します.
さらに関連する動画
09:08From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
17.1K
07:59A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
9.7K
関連する概念動画
Biosynthesis in Bacteria
1.0K
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
1.0K
Amino Acid Biosynthetic Pathways
1.8K
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
1.8K
Production of Pharmaceuticals
100
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
100
Regulation of Bacterial Virulence
81
Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
81
Inhibitors of Gram-positive Cell Wall Synthesis
225
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
225
Inhibitors of Bacterial Protein Synthesis
127
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
127
